Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Adamas Pharmaceuticals, Inc. (ADMS)

« Back to company index

ADMS Chatter Timeline

Stock Ticker for ADMS

Most Active Tweeters for ADMS

UserTweets
@stocknewstimes 4
@FlashAlert_me 3
@HealthcareBeat 3
@AmericanBanking 3
@WatchlistN 2

Recent Tweets for ADMS

SwingTradeBot @SwingTradeBot
20 DMA Support today: $REM $ADMS ... https://t.co/deOpbNqdR6
July 15th 2020, 3:07pm
StockNewsNow @StockNewsNow
$ADMS Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI® in Parkinson’s disease at the 2020 American A… https://t.co/9zbxrKqD9C
July 15th 2020, 3:07pm
HealthcareBeat @HealthcareBeat
Adamas announces post-hoc data supporting benefit of Gocovri in Parkinson's $ADMS https://t.co/FArs8VZqRK
July 15th 2020, 11:07am
MarketCurrents @MarketCurrents
$ADMS - Adamas announces post-hoc data supporting benefit of Gocovri in Parkinson's https://t.co/3fVChnHgFm
July 15th 2020, 11:07am
sbwcws @sbwcws
Adamas presents post-hoc Phase 3 data analysis for GOCOVRI $ADMS
July 15th 2020, 8:07am
otcdynamics @otcdynamics
$ADMS Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI® in Parkinson’s disease at the 2020 American A… https://t.co/1Lj8VCqFq8
July 15th 2020, 8:07am
FlashAlert_me @FlashAlert_me
$ADMS [15s. delayed]: Issued Press Release on July 15, 08:00:00: Adamas presents new post-hoc Phase 3 data analysis… https://t.co/jef4G3ic5j
July 15th 2020, 8:07am
stocknewstimes @stocknewstimes
-$0.60 Earnings Per Share Expected for Adamas Pharmaceuticals Inc $ADMS This Quarter https://t.co/MaRn5pLDpW
July 14th 2020, 2:07pm
stocknewstimes @stocknewstimes
Zacks: Analysts Anticipate Adamas Pharmaceuticals Inc $ADMS Will Post Quarterly Sales of $15.63 Million https://t.co/o15C7Xftx3
July 14th 2020, 1:07pm
fm23 @fm23
$ADMS https://t.co/w3pfAOS8yZ
July 13th 2020, 4:07pm
bbnsnews @bbnsnews
Analysts Set Adamas Pharmaceuticals Inc $ADMS PT at $9.67 https://t.co/4kK4ksRihG
July 13th 2020, 11:07am
ConsumerFeed @ConsumerFeed
Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/qTmz0tD5U8
July 12th 2020, 6:07am
WatchlistN @WatchlistN
Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/BF26aBQFP8
July 12th 2020, 6:07am
ThisLincolnian @ThisLincolnian
Adamas Pharmaceuticals $ADMS Trading 6.3% Higher https://t.co/ueh5jGFzvL
July 12th 2020, 2:07am
ConsumerFeed @ConsumerFeed
Analysts Set Adamas Pharmaceuticals Inc $ADMS PT at $9.67 https://t.co/QwWwulSnmq
July 11th 2020, 6:07am
WatchlistN @WatchlistN
Adamas Pharmaceuticals Inc $ADMS Receives $9.67 Consensus Target Price from Brokerages https://t.co/PjY3u12pMf
July 11th 2020, 6:07am
HealthcareBeat @HealthcareBeat
Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $ADMS https://t.co/Za3K2BOIEJ
July 11th 2020, 6:07am
EnterpriseLeade @EnterpriseLeade
Zacks: Analysts Anticipate Adamas Pharmaceuticals Inc $ADMS Will Post Quarterly Sales of $15.63 Million https://t.co/AyyDudANEg
July 11th 2020, 3:07am
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Adamas Pharmaceuticals Inc $ADMS Will Announce Quarterly Sales of $15.63 Million https://t.co/3HFCtivk9f #stocks
July 11th 2020, 3:07am
otcdynamics @otcdynamics
$ADMS Adamas Announces New Employment Inducement Grant https://t.co/hJ4ZudX5wp
July 10th 2020, 4:07pm
FlashAlert_me @FlashAlert_me
$ADMS [15s. delayed]: Issued Press Release on July 10, 16:05:00: Adamas Announces New Employment Inducement Grant https://t.co/76kzQZ1zzV
July 10th 2020, 4:07pm
HealthcareBeat @HealthcareBeat
Adamas Announces New Employment Inducement Grant $ADMS https://t.co/PXQzFecsi1
July 10th 2020, 4:07pm
stock_titan @stock_titan
$ADMS Adamas Announces New Employment Inducement Grant https://t.co/idcEe8J8oV
July 10th 2020, 4:07pm
EdgarInsider @EdgarInsider
FORM SC 13G/A recently SEC filed. $ADMS $BLK Adamas Pharmaceuticals Inc BlackRock Inc https://t.co/0WNxQe5RFd
July 10th 2020, 10:07am
fintel_io @fintel_io
BlackRock Inc. has filed an amended 13G/A, reporting 2.1% ownership in $ADMS - https://t.co/EXp6PHrtCr
July 10th 2020, 10:07am
FlashAlert_me @FlashAlert_me
$ADMS [15s. delayed] filed form SC 13G/A on July 10, 10:39:33 https://t.co/Egc2ApOE5v
July 10th 2020, 10:07am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/W25ksVYZpF #stocks
July 9th 2020, 11:07am
OlympiaReport @OlympiaReport
Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$0.60 Per Share https://t.co/uLbldcUbls
July 9th 2020, 11:07am
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/t6llfXKKWC
July 8th 2020, 11:07am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/Sjdd2y3KYk #stocks
July 8th 2020, 11:07am
stocknewstimes @stocknewstimes
Adamas Pharmaceuticals Inc $ADMS Receives Average Rating of “Hold” from Analysts https://t.co/CqAtMsvzU9
July 8th 2020, 11:07am
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals Inc $ADMS Receives Average Recommendation of “Hold” from Analysts https://t.co/2Cyaph5HSn
July 8th 2020, 11:07am
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/E1ryBeT0xo
July 8th 2020, 3:07am
stocknewstimes @stocknewstimes
Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/YxPGVBxLIw
July 8th 2020, 3:07am
stocknewstimes @stocknewstimes
Adamas Pharmaceuticals $ADMS Share Price Crosses Below Fifty Day Moving Average of $2.79 https://t.co/VtL4UFy13v
July 1st 2020, 3:07pm
DataTrials @DataTrials
$ADMS Phase 3 A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment…NC… https://t.co/M2LmS0tEJk
July 1st 2020, 6:07am
TEIStocks @TEIStocks
$ADMS looking interesting, near a well known support line. MACD and RSI not yet ready to take action, worth a watch… https://t.co/7fGgTOKJkN
June 30th 2020, 9:06am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals $ADMS – Research Analysts’ Recent Ratings Changes https://t.co/B3614hBZt9 #stocks
June 26th 2020, 4:06pm
TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/WBje8nMfFP
June 23rd 2020, 3:06am
stocknewstimes @stocknewstimes
Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/JpmJZCndCn
June 23rd 2020, 3:06am
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals $ADMS Rating Lowered to Hold at Zacks Investment Research https://t.co/XZWlb86dQX
June 23rd 2020, 3:06am
stocknewstimes @stocknewstimes
Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/m6deKB9qvl
June 22nd 2020, 6:06am
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/n5eeLZBXVF
June 22nd 2020, 6:06am
dakotafinancial @dakotafinancial
Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research https://t.co/98yhjP4ysj
June 22nd 2020, 6:06am
dakotafinancial @dakotafinancial
Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/A9rtrBzgtl
June 22nd 2020, 6:06am
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals Inc $ADMS Sees Large Decline in Short Interest https://t.co/UXVe5voMwh
June 22nd 2020, 6:06am
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals $ADMS Downgraded by Zacks Investment Research https://t.co/2FHqvjDAWx
June 22nd 2020, 6:06am
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals $ADMS Upgraded at Zacks Investment Research https://t.co/zagu7xQtxh
June 22nd 2020, 5:06am
dakotafinancial @dakotafinancial
Adamas Pharmaceuticals $ADMS Upgraded at Zacks Investment Research https://t.co/z1JXQSGQcb
June 22nd 2020, 5:06am
HealthcareBeat @HealthcareBeat
Adamas Pharmaceuticals Upgraded at Zacks Investment Research $ADMS https://t.co/Qegp8p6nmY
June 22nd 2020, 5:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.